Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061867 · ClinicalTrials.gov registry record · Phase 1
Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer
A Phase 1 study, sponsored by Imunon.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00061867: Completed Phase 1 study, sponsored by Imunon.
NCT00061867 is a Phase 1 study that has completed, run by Imunon. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00061867, a Phase 1 study, has completed, sponsored by Imunon.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin, use different ways to stop tumor cells from dividing so they stop growing or die. Microwave thermotherapy kills tumor cells by heating them to several degrees above body temperature. Combining liposomal doxorubicin with microwave thermotherapy may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of liposomal doxorubicin when given together with microwave thermotherapy in treating patients with prostate cancer.
Interventions
- DRUG pegylated liposomal doxorubicin hydrochloride
- PROCEDURE hyperthermia treatment
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-03 |
| Est. Completion | 2005-08 |
| Phase | Phase 1 |
What the finished NCT00061867 record still lists
NCT00061867 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which pegylated liposomal doxorubicin hydrochloride is the first listed.
NCT00061867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00061867 about?
NCT00061867 is a clinical study titled "Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer". RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin, use different ways to stop tumor cells from dividing so they stop growing or die. Microwave thermotherapy kills tumor cells by heating them to several degrees above body temperature. Combining liposomal doxorubicin with microwave ...
What is the current status of trial NCT00061867?
This trial is currently completed. It is a Phase 1 study. The study started on 2003-03. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00061867?
The interventions under investigation include: pegylated liposomal doxorubicin hydrochloride (DRUG), hyperthermia treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00061867?
This trial is sponsored by Imunon, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia